GKB Ophthalmics Ltd
Incorporated in 1981, GKB Ophthalmics Ltd is in the business of manufacture and sale of ophthalmic lenses made up of Glass and Plastic
- Market Cap ₹ 49.4 Cr.
- Current Price ₹ 97.9
- High / Low ₹ 136 / 74.1
- Stock P/E
- Book Value ₹ 40.6
- Dividend Yield 0.00 %
- ROCE -4.96 %
- ROE -13.4 %
- Face Value ₹ 10.0
Pros
- Company's working capital requirements have reduced from 54.7 days to 40.7 days
Cons
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of 0.46% over past five years.
- Company has a low return on equity of -10.0% over last 3 years.
- Contingent liabilities of Rs.17.2 Cr.
- Promoter holding has decreased over last 3 years: -8.63%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: FMCG Industry: Personal Care - Indian
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
32.21 | 31.38 | 29.85 | 31.17 | 40.65 | 37.43 | 30.47 | 25.56 | 21.34 | 27.05 | 27.73 | 31.18 | 31.08 | |
30.75 | 25.58 | 30.63 | 33.61 | 41.05 | 38.41 | 31.52 | 26.29 | 21.63 | 27.44 | 28.82 | 32.46 | 33.97 | |
Operating Profit | 1.46 | 5.80 | -0.78 | -2.44 | -0.40 | -0.98 | -1.05 | -0.73 | -0.29 | -0.39 | -1.09 | -1.28 | -2.89 |
OPM % | 4.53% | 18.48% | -2.61% | -7.83% | -0.98% | -2.62% | -3.45% | -2.86% | -1.36% | -1.44% | -3.93% | -4.11% | -9.30% |
1.25 | 1.18 | 1.72 | 23.08 | 4.11 | 1.05 | 2.62 | 1.38 | 2.33 | 1.91 | 2.09 | 2.08 | 2.07 | |
Interest | 2.88 | 2.86 | 2.49 | 1.61 | 1.26 | 1.23 | 1.39 | 1.35 | 1.34 | 1.34 | 1.50 | 1.59 | 1.65 |
Depreciation | 1.15 | 1.18 | 1.48 | 1.42 | 1.34 | 1.58 | 3.43 | 3.47 | 2.99 | 2.49 | 2.54 | 2.59 | 2.61 |
Profit before tax | -1.32 | 2.94 | -3.03 | 17.61 | 1.11 | -2.74 | -3.25 | -4.17 | -2.29 | -2.31 | -3.04 | -3.38 | -5.08 |
Tax % | -9.85% | 71.77% | -25.41% | 22.43% | 31.53% | -6.20% | -14.77% | 0.00% | -7.86% | 0.00% | -5.26% | 1.18% | |
-1.19 | 0.83 | -2.26 | 13.66 | 0.76 | -2.58 | -2.78 | -4.17 | -2.11 | -2.31 | -2.88 | -3.42 | -5.14 | |
EPS in Rs | -2.86 | 2.00 | -5.44 | 32.89 | 1.83 | -6.21 | -5.99 | -8.27 | -4.19 | -4.58 | -5.71 | -6.78 | -10.21 |
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | 0% |
5 Years: | 0% |
3 Years: | 13% |
TTM: | 4% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | 3% |
3 Years: | % |
TTM: | -35% |
Stock Price CAGR | |
---|---|
10 Years: | 9% |
5 Years: | 8% |
3 Years: | 4% |
1 Year: | -1% |
Return on Equity | |
---|---|
10 Years: | -10% |
5 Years: | -9% |
3 Years: | -10% |
Last Year: | -13% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 4.15 | 4.15 | 4.15 | 4.15 | 4.15 | 4.15 | 4.64 | 5.04 | 5.04 | 5.04 | 5.04 | 5.04 | 5.04 |
Reserves | 13.01 | 13.84 | 11.14 | 24.80 | 25.44 | 22.78 | 30.03 | 30.21 | 27.73 | 25.36 | 22.48 | 18.95 | 15.43 |
15.09 | 12.51 | 8.62 | 7.22 | 7.19 | 9.93 | 10.05 | 10.04 | 11.97 | 11.75 | 11.22 | 11.08 | 12.04 | |
19.75 | 20.67 | 24.79 | 11.36 | 10.22 | 8.57 | 10.45 | 11.40 | 12.13 | 11.74 | 10.41 | 13.32 | 15.76 | |
Total Liabilities | 52.00 | 51.17 | 48.70 | 47.53 | 47.00 | 45.43 | 55.17 | 56.69 | 56.87 | 53.89 | 49.15 | 48.39 | 48.27 |
12.67 | 13.61 | 11.72 | 12.49 | 16.43 | 16.98 | 24.29 | 24.83 | 22.28 | 21.27 | 17.28 | 15.89 | 15.29 | |
CWIP | 2.29 | 0.57 | 0.57 | 0.57 | 0.57 | 0.24 | 0.00 | 0.00 | 1.23 | 3.29 | 3.82 | 3.78 | 3.78 |
Investments | 4.23 | 5.53 | 5.53 | 10.45 | 3.77 | 0.66 | 0.32 | 3.21 | 12.22 | 11.90 | 11.90 | 11.90 | 11.90 |
32.81 | 31.46 | 30.88 | 24.02 | 26.23 | 27.55 | 30.56 | 28.65 | 21.14 | 17.43 | 16.15 | 16.82 | 17.30 | |
Total Assets | 52.00 | 51.17 | 48.70 | 47.53 | 47.00 | 45.43 | 55.17 | 56.69 | 56.87 | 53.89 | 49.15 | 48.39 | 48.27 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1.97 | 5.47 | 5.87 | -11.90 | -4.20 | -3.71 | 5.31 | 6.13 | 2.11 | 2.33 | -1.14 | 1.36 | |
-1.02 | -0.65 | 0.13 | 14.74 | 5.50 | 2.28 | -8.63 | -5.68 | -11.52 | -0.83 | 2.40 | 0.37 | |
-0.95 | -4.82 | -6.00 | -2.81 | -1.29 | 1.41 | 9.21 | 3.31 | 0.61 | -1.50 | -2.03 | -1.74 | |
Net Cash Flow | 0.00 | 0.00 | 0.00 | 0.02 | 0.00 | -0.02 | 5.88 | 3.76 | -8.80 | 0.00 | -0.78 | 0.00 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 154.57 | 175.87 | 176.57 | 92.63 | 66.00 | 101.81 | 129.49 | 148.08 | 127.25 | 80.96 | 64.23 | 80.30 |
Inventory Days | 432.20 | 409.77 | 350.98 | 285.25 | 283.50 | 264.10 | 154.90 | 133.50 | 256.82 | 141.86 | 161.81 | 102.38 |
Days Payable | 208.29 | 232.25 | 362.47 | 119.63 | 106.91 | 84.89 | 171.32 | 222.98 | 251.31 | 158.86 | 139.11 | 157.83 |
Cash Conversion Cycle | 378.48 | 353.40 | 165.08 | 258.24 | 242.59 | 281.01 | 113.07 | 58.61 | 132.77 | 63.96 | 86.93 | 24.86 |
Working Capital Days | 139.72 | 128.88 | 65.66 | 152.00 | 144.02 | 190.74 | 112.60 | 86.54 | 101.26 | 51.14 | 72.26 | 40.74 |
ROCE % | 7.63% | 17.31% | -3.86% | -6.26% | -0.77% | -4.13% | -8.09% | -6.29% | 0.13% | -2.14% | -3.96% | -4.96% |
Documents
Announcements
-
Outcome Of The Board Meeting Held On January 03, 2025 And Execution Of Loan Agreement
3 Jan - Board approved unsecured loan of Rs 5 crores.
-
Sanctioning Of Loan Amount Of Rs. 5.00 Crores By Subsidiary Company To GKB Ophthalmics Limited, Holding Company.
2 Jan - Approval of Rs. 5 Crore loan for working capital.
-
Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015
31 Dec - Director K.G. Gupta purchased 500 equity shares.
-
Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015
31 Dec - Disclosure of insider trading by Krishna Gopal Gupta & Sons.
-
Closure of Trading Window
27 Dec - Closure of trading window until financial results declaration.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
Product Profile:[1]
a) Single Vision: 1.498 CR-39, 1.50 Blucheck, 1.56 Blucheck 1.56 DayNite, 1.56 DayNite FAST CHANGE, 1.50 Q-SHADE +, 1.50 SunSensor
b) Bifocal: 1.498 CR-39, 1.50 Blucheck, 1.56 Blucheck, 1.56 DayNite, 1.56 DayNite Fast Change
c) Progressive: 1.498 CR-39, 1.50 Blucheck, 1.56 DayNite, 1.56 DayNite Fast Change
d) Aspheric: 1.498 CR-39